{
    "clinical_study": {
        "@rank": "104121", 
        "arm_group": {
            "arm_group_label": "Serotype distribution"
        }, 
        "biospec_descr": {
            "textblock": "Blood, CSF and/or other sterile body areas (catheter, pleural fluid, parasynthesis fluid,\n      pericardial fluid, synovial fluid, BAL)"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The aim of this study is to specify the serotype distribution of Streptococcus pneumoniae\n      that causes invasive diseases at children and adults in Turkey."
        }, 
        "brief_title": "Serotype Distribution and Antibiotic Sensitivity of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey: Multi-centered, Retrospective Laboratory Trial", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pneumococcal Diseases", 
        "condition_browse": {
            "mesh_term": "Pneumonia"
        }, 
        "detailed_description": {
            "textblock": "Non-interventional observational study Descriptive analysis will be conducted."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes\n        invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other\n        sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid,\n        synovial fluid, BAL) of the adults of 18 years of age or older with children that are\n        younger than 18 years old at these centers and laboratories will be defined.\n\n        Exclusion Criteria:\n\n        Isolation of any other microorganism than pneumococcus at the same sample."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Pneumococcal isolates that are obtained from the blood, CSF and/or other sterile body\n        areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid,\n        BAL) with the aim of routine laboratory diagnosis from the pediatric patients that are\n        younger than 18 years old (\u226418), who are accepted to the pediatric clinic with the\n        diagnosis of meningitides, bacteremia - sepsis or pneumonia, will be included in the\n        trial.\n\n        S.pneumoniae isolates that meet the inclusion criteria and that are obtained from the\n        invasive clinical samples of the adult patients that are over 18 years old (>18) and\n        applied to the hospital are included in the trial."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01810861", 
            "org_study_id": "B1851148"
        }, 
        "intervention": {
            "arm_group_label": "Serotype distribution", 
            "description": "This is a non-interventional study.", 
            "intervention_name": "serotype distribution", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "serotype distribution", 
            "streptococcus pneumoniae", 
            "pneumonia"
        ], 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1851148&StudyName=Serotype%20Distribution%20and%20Antibiotic%20Sensitivity%20of%20Streptococcus%20Pneumoniae%20That%20Causes%20Invasive%20Diseases%20at%20Children%20and%20Adults%20in%20Turkey%"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Balcova", 
                        "country": "Turkey", 
                        "state": "Izmir", 
                        "zip": "35340"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gaziantep", 
                        "country": "Turkey", 
                        "state": "Turkiye"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey", 
                        "state": "Turkiye"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Adana", 
                        "country": "Turkey", 
                        "zip": "01330"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antalya", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bursa", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey", 
                        "zip": "34662"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kahramanmaras", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kayseri", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Samanpazari, Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trabzon", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Van", 
                        "country": "Turkey"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Serotype Distribution and Antibiotic Sensitivity of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey: Multi-centered, Retrospective Laboratory Trial", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_contact_backup": {
            "email": "PfizerCancerTrials@emergingmed.com", 
            "last_name": "Pfizer Oncology Clinical Trial Information Service", 
            "phone": "1-877-369-9753"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Identification of S. pneumoniae serotype distribution", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01810861"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Identification of antibiotic susceptibility of the isolates", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}